The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with solid tumors: Clinical data from advanced cervical cancer and platinum-resistant recurrent ovarian cancer cohorts.
 
Lingying Wu
No Relationships to Disclose
 
Guiling Li
No Relationships to Disclose
 
Shuqing Wei
No Relationships to Disclose
 
Ruonan Liu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Xiumin Li
No Relationships to Disclose
 
Yongsheng Li
No Relationships to Disclose
 
Chunyan Wang
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Xiaofeng Yang
No Relationships to Disclose
 
An Lin
No Relationships to Disclose
 
Zhiquan Qin
No Relationships to Disclose
 
Tao Wu
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Yi Huang
No Relationships to Disclose
 
Kejun Nan
No Relationships to Disclose
 
Ping Duan
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Yanru Qin
No Relationships to Disclose